← Leaderboards
Vladimir B Mikheev
Battelle Pacific Northwest Laboratories
$814,763
Attributed
$2,444,289
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $678.6K · FY2018–21$1M$750K$500K$250K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$2,444,289 · 1
By mechanism
R01$2,444,289 · 1
Top collaborators
- Justin Gary Teeguarden5 shared
- Charles K Ansong3 shared
- Wei-Jun Qian2 shared
Most similar at Battelle Pacific Northwest Laboratories
Same institution · by research overlap
- Charles Timchalk$7,098,821
- Richard A Corley$23,539,385
- Joel G Pounds$3,784,548
- Justin Gary Teeguarden$3,918,065
- Charles K Ansong$4,159,791
Others in their field
Other Emerging Leaders on “Glycerol”
- Vaia Lida Chatzi · University Of Southern California$8,101,292
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$8,061,604
- Joshua Wiley Knowles · Stanford University$6,163,002
- Paul Cohen · Rockefeller University$5,891,007
- Li Ye · Stanford University$5,701,260
- Courtney Marie Peterson · University Of Alabama At Birmingham$4,655,471
Research focus
GlycerolAldehydesAerosolizedGenerationsBaseBiologicalCellsAnimal ModelAerosolsComparativeComplementComplex MixturesDepositionDevicesDoseDosimetryCigarette SmokeElectronic CigaretteCigarette SmokingEventExposure ToFlavoringFunctional DisorderHazard
Grant awards (5)
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$555,762
R01 · FY2021 · HL
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$576,908
R01 · FY2020 · HL
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$101,687
R01 · FY2020 · HL
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$597,367
R01 · FY2019 · HL
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposure$612,565
R01 · FY2018 · HL